Skip to content
VC still interested in biotech, says McKinsey
The market is volatile, to say the least – but it’s not entirely bad for biotechs, especially those with innovative science, said McKinsey & […]
VC still interested in biotech, says McKinsey Read More »
Health
FDA Accelerated Approval Pathway must be preserved, experts say
The FDA’s Accelerated Approval Pathway must be preserved against current threats as it has been a lifeline for patients with rare diseases, life-threatening conditions,
FDA Accelerated Approval Pathway must be preserved, experts say Read More »
BIO Unbound: ‘Science is limitless when we limit science less’
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
COVID lessons on manufacturing, distribution, regulation
Asked what this pandemic taught us that will help us prepare for the next one, a panel of experts mentioned the need to improve
COVID lessons on manufacturing, distribution, regulation Read More »
How do you get an entire population vaccinated and boosted?
The COVID-19 pandemic shook up the global health care system in ways that were more unique and acute than in years past. Yet, the
How do you get an entire population vaccinated and boosted? Read More »
Women’s health ‘woefully underfunded’ – but that’s changing
About 50% of the world’s population are women – and women account for around 85% of spending decisions, said Cathy Friedman, Executive Venture Partner
Women’s health ‘woefully underfunded’ – but that’s changing Read More »
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode
On Day 2, the Good Day BIO Live team brings you exclusive interviews with Johnson & Johnson’s Pierre Theodore, Travere Therapeutics’ Eric Dube, Organon’s Kevin Ali,
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode Read More »
Biotech can be part of the solution to health inequity – here’s how
Global health equity is a complex problem that impacts every country, and the biotech industry can be part of the solution, according to panelists
Biotech can be part of the solution to health inequity – here’s how Read More »
Inflation’s not hitting health – and drug prices have lowest increases, says report
The health care sector is not being hit by overall inflation – and prescription drug prices are seeing the lowest increases, says a new
Inflation’s not hitting health – and drug prices have lowest increases, says report Read More »
Biotech leaders discuss how to build a more inclusive industry
The biotechnology industry’s focus on diversity, equity, and inclusion (DEI) in recent years has brought about improvement, but we still have work to do,
Biotech leaders discuss how to build a more inclusive industry Read More »